PANDAS is, by its own diagnostic criteria, a childhood condition, with onset required between age three and the start of puberty. That said, the question of whether adults can develop the same syndrome or carry it into adulthood has been debated since the concept was first described in the late 1990s. Published case reports describe adults who develop sudden-onset obsessive-compulsive symptoms after streptococcal infections in ways that closely mirror what happens in children, and some researchers have argued that the biology behind PANDAS does not simply switch off when a person turns eighteen.
What PANDAS Actually Is
PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. The name itself telegraphs its age restriction. Five working criteria define it: the person must meet diagnostic criteria for OCD or a tic disorder; symptoms must begin between roughly age three and puberty; the course must be episodic, with dramatic, abrupt flare-ups; symptom onset or worsening must be tied in time to a group A streptococcal (strep) infection; and neurological abnormalities like tics, motor hyperactivity, or involuntary choreiform movements must be present.1Frontiers in Pediatrics. Diagnostic Approach to Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Narrative Review of Literature Data Confirming a strep infection through a throat swab or elevated antibody titers is also required.
The related umbrella term PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) broadens the picture by dropping the strep requirement. Under PANS, the trigger can be any infection or even a non-infectious immune event. But both constructs share the word “pediatric,” and that word is doing real clinical work: it tells doctors the condition belongs in childhood, not adulthood.
Why the Adult Question Keeps Coming Up
Biology does not respect diagnostic labels. The autoimmune mechanism thought to drive PANDAS involves the immune system producing antibodies against strep bacteria that also cross-react with brain tissue, particularly the basal ganglia. Research in animal models has shown that repeated strep infections can cause a type of immune cell to migrate from the nasal passages into the brain, breaking down the blood-brain barrier and allowing autoantibodies to enter the central nervous system, damaging neural circuits.2PubMed Central. Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis More recent work has identified a specific signaling pathway in which an inflammatory molecule acts on brain immune cells to drive that barrier breakdown.3PubMed Central. Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in post-streptococcal encephalitis
None of this machinery is exclusive to children. Adults still get strep infections, still have immune systems capable of producing cross-reactive antibodies, and still have basal ganglia vulnerable to autoimmune attack. The pediatric restriction in the diagnostic criteria reflects the epidemiology of strep throat (it peaks in school-age children) and the clinical context in which the syndrome was first recognized. It does not reflect a proven biological boundary that makes the condition impossible after puberty.
Case Reports of Adults With PANDAS-Like Illness
Several published case reports have described adults whose clinical pictures closely resemble childhood PANDAS. One early and influential report described a patient whose illness was “similar to PANDAS in presentation,” leading the authors to suggest that post-streptococcal disease could result in adult-onset OCD.4PubMed. The question of PANDAS in adults A separate case report from an Indian psychiatry journal described what appeared to be a PANDAS-like syndrome in an adult patient, with the authors cautioning that clinicians should keep the syndrome in mind even in grown-up patients.5Indian Journal of Private Psychiatry. PANDAS in an Adult?: A Case Report
One particularly detailed report followed a young man who first developed sudden psychosis and confusion after strep infections at age seventeen, with elevated strep antibody titers. Over the following decade he cycled through antipsychotics, antibiotics, tonsillectomy, and intravenous immunoglobulin, experiencing repeated remissions and relapses. At twenty-seven, he received a combination of plasma exchange, the immunosuppressant rituximab, and an antibiotic, which finally produced sustained improvement.6PubMed Central. Plasmapheresis, Rituximab, and Ceftriaxone Provided Lasting Improvement for a 27-Year-Old Adult Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) His case is a useful illustration of two paths an adult might take to an “adult PANDAS” diagnosis: either childhood onset that persists into adulthood, or a first episode that strikes in the late teenage years and continues.
These reports are compelling but individually they prove very little. Case reports sit near the bottom of the evidence hierarchy because they describe single patients without control groups. Still, they matter here because large-scale studies of adult-onset PANDAS essentially do not exist, and these individual stories are what prompted researchers to look more systematically at whether strep-triggered neuropsychiatric illness can develop after childhood.
What the Symptoms Look Like
Whether in children or in adults described in case reports, the hallmark of PANDAS is the sudden, dramatic onset of psychiatric and neurological symptoms following a strep infection. The onset is often described by parents and patients as an overnight transformation. In children studied under the broader PANS criteria, the most common features beyond OCD and tics include sleep disturbances, academic difficulties, irritability, developmental regression, motor abnormalities, hallucinations, anxiety, aggression, heightened sensitivity to sensory stimuli, and emotional instability.7PubMed. Pediatric acute-onset neuropsychiatric syndrome: A single-center retrospective study
In adult case reports, the symptoms tend to center on OCD, psychosis, and severe anxiety. Some adults describe a rapid escalation of intrusive thoughts, compulsive behaviors, or a sudden inability to function at work or in relationships. The episodic quality is often prominent: symptoms flare with infections and wane during healthy periods, though over time the cycles can become less clear-cut, especially if the person has been ill for years.
One point that gets lost in online discussions is that many of these symptoms overlap extensively with ordinary-onset OCD, Tourette syndrome, and other psychiatric conditions. What distinguishes PANDAS is not the symptoms themselves but their abrupt onset in clear temporal relationship to a strep infection, plus the episodic waxing and waning pattern. An adult with gradually worsening OCD over months or years, absent any identifiable infectious trigger, does not fit the pattern, even if they happen to test positive for strep antibodies.
The Diagnostic Problem in Adults
Diagnosis is the hardest part of the entire PANDAS conversation, and it gets exponentially harder in adults. For children, the process already has well-known pitfalls. The standard blood tests for strep exposure, including anti-streptolysin O (ASO) and anti-DNase B titers, document that strep exposure happened but do not prove it caused the neuropsychiatric symptoms.8Psychiatria Polska. PANDAS in the post-COVID era: links to group A Streptococcus and implications for pediatric neuropsychiatry ‒ a narrative review A recent clinical report from the American Academy of Pediatrics went further, stating that antistreptococcal antibody testing is not recommended for evaluating acute strep infection in this context because sustained high or low titers are difficult to interpret and do not reliably indicate recent infection.9Pediatrics. Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Report
For adults the situation is worse. By the time someone reaches their twenties or thirties, they have likely been exposed to strep multiple times, and antibody levels can be chronically elevated or fluctuating for reasons unrelated to any current neuropsychiatric event. A study of fifty young adult psychiatric patients (ages eighteen to thirty-four) with histories suggestive of past strep exposure found only a modest statistical association between ASO titers and PANDAS-relevant symptom scores, and even that weak signal faded after adjusting for childhood psychiatric history.10BRAIN. Broad Research in Artificial Intelligence and Neuroscience. Streptococcal Seroreactivity and Neuropsychiatric Symptom Patterns Relevant to PANS/PANDAS in Young Adults The authors were explicit that their findings do not establish adult PANDAS, active neuroinflammation, or ASO as a useful diagnostic marker in adults.
There is no blood test, brain scan, or biomarker that can confirm PANDAS in any age group. Brain imaging studies have shown suggestive findings, like increased metabolic activity in the basal ganglia on PET scans and signs of neuroinflammation in those brain regions among children with PANDAS.11PubMed Central. Altered cerebral glucose metabolism normalized in a patient with a pediatric autoimmune neuropsychiatric disorder after streptococcal infection (PANDAS)-like condition following treatment with plasmapheresis: a case report12PubMed. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195 But these are research findings, not clinical diagnostic tools available to a patient walking into a doctor’s office.
When Triggers Are Not Strep
Part of the complexity for adults is that the same type of sudden-onset neuropsychiatric presentation can be triggered by infections other than strep. Under the PANS umbrella, any infectious or post-infectious immune trigger qualifies. In children studied through genetic and clinical workups, strep was the most common trigger, but intracellular bacteria and viruses also played a role.13PubMed Central. Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing
Case reports have documented PANS-like presentations triggered by tick-borne infections. One adolescent was diagnosed with anorexia nervosa at an eating disorder clinic after severe food restriction and an irrational fear of weight gain. Her history pointed toward systemic infections, and she tested positive for multiple tick-borne pathogens and Mycoplasma. After antimicrobial treatment, her eating disorder symptoms resolved completely.14PubMed Central. Anorexia Nervosa Caused by Polymicrobial Tick-Borne Infections: A Case Study The implication is that infection-triggered neuropsychiatric illness is not limited to a single pathogen, and adults who develop sudden psychiatric symptoms after any significant infection may warrant investigation for an immune-mediated process rather than a purely psychiatric one.
For adults trying to make sense of their symptoms, this broader lens can be both helpful and confusing. It expands the number of plausible explanations but also makes diagnosis even less straightforward since there is no single pathogen to test for.
Treatment Options for Adults
Treatment research for PANDAS is thin across all age groups. A systematic review found that rigorously conducted treatment studies are scarce and published work carries a high risk of bias. The treatments that have been investigated include penicillin, azithromycin, intravenous immunoglobulin, plasma exchange, tonsillectomy, cognitive behavioral therapy, NSAIDs, and corticosteroids.15PubMed. Treatment of PANDAS and PANS: a systematic review Expert opinion holds that SSRIs and cognitive behavioral therapy remain first-line recommendations for the OCD component, with immunological treatments reserved for severe or refractory cases.16PubMed. An expert opinion on PANDAS/PANS: highlights and controversies
For adults specifically, the evidence is almost entirely limited to case reports and small series. A study investigated therapeutic plasma exchange in sixteen late-adolescent and adult PANDAS/PANS patients and found improvement in over half of those with available follow-up data.17PubMed Central. Therapeutic plasma exchange in adolescent and adult patients with autoimmune neuropsychiatric disorders associated with streptococcal infections That is the closest thing to a systematic look at treating adults with this condition, and sixteen patients is a very small sample. The case of the twenty-seven-year-old man who improved on plasma exchange, rituximab, and ceftriaxone after a decade of illness offers hope but remains a single patient’s story.6PubMed Central. Plasmapheresis, Rituximab, and Ceftriaxone Provided Lasting Improvement for a 27-Year-Old Adult Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
In practical terms, an adult who suspects a strep-triggered neuropsychiatric condition will likely find that most general psychiatrists are unfamiliar with the concept and may be skeptical. Specialists who treat PANDAS tend to cluster at academic medical centers and in a handful of private practices. Access is uneven and can be expensive, a concern echoed in the broader medical literature on neuroimmune diagnoses.
The Skepticism Around Adult PANDAS
It would be misleading to present the adult PANDAS concept without acknowledging that it remains genuinely controversial in mainstream medicine. The skepticism operates on two levels. First, even in children, PANDAS as a distinct entity has faced criticism. Some researchers argue the criteria are too narrow and that the focus on strep obscures a broader landscape of infection-triggered neuropsychiatric illness. Others question whether the temporal association between strep and symptom flares is as clean as early reports suggested, given how common strep is in children and how difficult it is to establish causation from timing alone.
Second, extending the concept to adults introduces additional uncertainty. Adults have more complex psychiatric histories, more cumulative immune exposures, and more potential confounders. The modest association between strep antibodies and neuropsychiatric symptoms seen in young adults largely vanished once childhood psychiatric history was accounted for, raising the possibility that what looks like adult-onset PANDAS could be preexisting psychiatric vulnerability rather than a new autoimmune process.10BRAIN. Broad Research in Artificial Intelligence and Neuroscience. Streptococcal Seroreactivity and Neuropsychiatric Symptom Patterns Relevant to PANS/PANDAS in Young Adults
Critics have also pointed out that a cottage industry of unvalidated treatments has grown up around PANDAS and related diagnoses, including intravenous immunoglobulin, long-term antibiotics, and plasma exchange administered outside of established clinical guidelines. The risk is that patients receive expensive and sometimes invasive treatments based on a diagnosis that lacks the evidence base to support it, while potentially treatable conventional psychiatric conditions go unaddressed.
What the Gut Might Have to Do With It
An emerging but still preliminary research angle involves the gut microbiome. A small body of literature suggests that streptococcal infections may alter the composition of gut bacteria in PANDAS patients, reducing microbial diversity and shifting bacterial populations in ways that promote chronic inflammation. Elevated markers of oxidative stress have been observed, and the presence of bacterial endotoxins in the bloodstream may contribute to neuroinflammation through what researchers call the gut-brain axis.18PubMed Central. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and gut microbiota composition: what do we know? This work is almost entirely in children and remains hypothesis-generating rather than clinically actionable. No one can yet recommend a specific probiotic or dietary intervention for PANDAS based on solid evidence. But the research underscores that the condition likely involves more than a simple antibody-attacks-brain model.
Practical Guidance for Adults Who Suspect a Connection
If you are an adult experiencing sudden-onset OCD, tics, or other neuropsychiatric symptoms that seem to flare around infections, here is what is worth knowing. First, the honest state of the science is that no validated diagnostic pathway exists for adult PANDAS. You cannot walk into a lab, get a test, and get a definitive answer. Elevated ASO titers alone do not make the diagnosis, and normal titers do not rule it out.
Second, the most important step is a thorough psychiatric and medical evaluation. The sudden-onset pattern can also occur in autoimmune encephalitis (which has better-established diagnostic criteria and treatment protocols), thyroid disorders, lupus affecting the brain, and other conditions that are more readily testable and treatable. Ruling those out is not optional. An adult fixated on the PANDAS label who skips a comprehensive workup risks missing something more actionable.
Third, if you had childhood-onset PANDAS or PANS and your symptoms have persisted or re-emerged in adulthood, you may have an easier time finding a clinician willing to continue treatment along those lines. The pediatric diagnosis provides a clinical anchor that purely adult-onset cases lack.
Fourth, standard psychiatric treatments for OCD and tics, including SSRIs and cognitive behavioral therapy, have far more evidence behind them than any immune-targeted intervention for PANDAS in adults. Starting with proven treatments makes sense even if you believe an autoimmune process is involved. These approaches are not in conflict; treating the symptoms while investigating the cause is a reasonable strategy.
Fifth, be cautious about clinicians who offer a PANDAS diagnosis based primarily on antibody titers and then recommend expensive immunological treatments without first conducting a broad differential workup. The overlap between PANDAS symptoms and common psychiatric conditions is enormous, and enthusiasm for a unifying autoimmune explanation can sometimes outpace the evidence.
Neuroimaging and the Search for Objective Markers
One of the reasons PANDAS remains so contentious is the lack of any objective test to confirm it. Brain imaging has offered intriguing leads but nothing approaching a diagnostic standard. PET scans of children with PANDAS have shown increased binding of a radiotracer that marks activated immune cells in the brain, specifically in the basal ganglia, with a different pattern from children with Tourette syndrome.12PubMed. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195 In at least one case report, abnormal basal ganglia metabolism on a PET scan normalized after plasma exchange treatment.11PubMed Central. Altered cerebral glucose metabolism normalized in a patient with a pediatric autoimmune neuropsychiatric disorder after streptococcal infection (PANDAS)-like condition following treatment with plasmapheresis: a case report
These findings are consistent with the theory that inflammation in specific brain regions drives the symptoms, but they come from small studies and individual cases. PET scanning is expensive, involves radiation exposure, and is not available at most hospitals for this purpose. No imaging professional society recommends PET scans for PANDAS diagnosis. The gap between “we can see something interesting on a research scan” and “we can use this to diagnose patients” remains wide, and there is no clear timeline for when or whether it will close. For adults wondering if imaging could settle their diagnostic question, the answer for now is that it cannot.